Economic Burden of Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) in the US

被引:0
|
作者
Aly, Abdalla
Bapat, Bela
Ray, Saurabh
Chen, Zhiyong
Botteman, Marc
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3386
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Pooled Safety Analysis of Quizartinib Monotherapy in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
    Cortes, Jorge E.
    Ganguly, Siddhartha
    Kraemer, Alwin
    Levis, Mark J.
    Martinelli, Giovanni
    Perl, Alexander E.
    Russell, Nigel H.
    Choi, Youngsook
    Mendell, Jeanne
    Namuyinga, Ruth
    Hoang Pham
    Said, Nabil
    Wang, Yibin
    Mitov, Tsvetomir
    Kim, Ben
    Khaled, Samer K.
    BLOOD, 2019, 134
  • [2] A Phase IB/II Study of Lirilumab with Azacytidine in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
    Daver, Naval
    Boddu, Prajwal
    Ravandi, Farhad
    Jabbour, Elias
    Borthakur, Gautam
    DiNardo, Courtney
    Konopleva, Marina
    Pemmaraju, Naveen
    Kadia, Tapan
    Jain, Nitin
    Pierce, Sherry
    Hussain, Nawar
    Ning, Jing
    Nogueras-Gonzalez, Graciela
    Basu, Sreyashi
    Cortes, Jorge
    Sharma, Padmanee
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S6 - S7
  • [3] A Phase 1 Trial of Valemetostat in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
    Erba, Harry P.
    Oluwole, Olalekan O.
    Bixby, Dale
    Rampal, Raajit K.
    Fathi, Amir T.
    Paliwal, Prashni
    Jin, Jin
    Inoue, Ai
    Daver, Naval
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S311 - S312
  • [4] Survival of Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Patients Receiving Stem Cell Transplantation (SCT)
    Nath, Rajneesh
    Reddy, Vijay
    Kapur, Anil
    Gebregergish, Samron
    Gurskyte, Laura
    Kulakova, Margarita
    Heeg, Bart
    Berger, Mark S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [5] A Phase 1 Study of WU-NK-101 in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
    Cashen, Amanda F.
    Liu, Hongtao
    Al Malki, Monzr M.
    Zeidner, Joshua F.
    Foster, Matthew C.
    Pannunzio, Angela
    Ramsey, Brett
    Baughman, Jan
    Muth, John
    Bakkacha, Ouiam
    McNulty, Eileen
    Jacobs, Kenneth
    Davidson-Moncada, Jan K.
    Wei, Andrew H.
    BLOOD, 2022, 140 : 12740 - 12741
  • [6] COSTS OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) IN COLOMBIA
    Lasalvia, P.
    Gil, Rojas Y.
    Arciniegas Moreno, K.
    Saturnino, Ltm
    VALUE IN HEALTH, 2022, 25 (01) : S59 - S59
  • [7] Efficacy and cost-effectiveness of clofarabine with high-dose cytarabine for treatment of relapsed/refractory acute myeloid leukemia (R/R AML).
    Nunnery, Sara
    Wang, Dorothy
    Tan, Marisela
    Fong, Richard
    Lo, Mimi Ming
    Olin, Rebecca L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Sequential conditioning with high dose melphalan followed by busulfan and fludarabine in eldery patients with relapsed or refractory (r/r) acute myeloid leukemia (AML)
    Urbahn, M. -A.
    Reicherts, C.
    Pohlmann, A.
    Call, S.
    Esseling, E.
    Floeth, M.
    Marx, J.
    Albring, J.
    Mikesch, J. -H.
    Schliemann, C.
    Lenz, G.
    Stelljes, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 101 - 101
  • [9] Burden of relapsed/refractory (RR) acute myeloid leukemia.
    Panjabi, Sumeet
    Hines, Dionne M.
    McGuiness, Catherine Balderston
    Yucel, Emre
    Yea, Steven
    McIver, Zachariah
    Wade, Rolin L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] NPM1 Mutations Do Not Retain a Favorable Prognostic Impact in Adults with Advanced Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
    Venugopal, Sangeetha
    Issa, Ghayas C.
    Konopleva, Marina
    DiNardo, Courtney D.
    Borthakur, Gautam
    Jabbour, Elias J.
    Pemmaraju, Naveen
    Yilmaz, Musa
    Short, Nicholas J.
    Maiti, Abhishek
    Sasaki, Koji
    Masarova, Lucia
    Pierce, Sherry A.
    Takahashi, Koichi
    Tang, Guilin
    Loghavi, Sanam
    Andreeff, Michael
    Bhalla, Kapil N.
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kantarjian, Hagop
    Daver, Naval
    BLOOD, 2021, 138